Paul Molloy

Mr Molloy has twenty-five years' experience a range of public, private and venture capitalfunded healthcare companies. He is currently President and CEO of Clearflow Inc., a US-based medical device company. Before joining ClearFlow, he was CEO at VasoNova Inc.- a Silicon Valley-based, venturefunded vascular navigation company which was acquired by Teleflex Inc. (NYSE, TFX), in January 2011. Following the acquisition, he was appointed President of Teleflex' division - ARROW Vascular - having full P&L responsibilities for direct sales, US and overseas manufacturing plants, R&D and strategic planning at the corporate level. Mr Molloy has also also exited a number of US medical devices firms, including publicly traded cerebral oxygenation monitoring firm, CAS Medical Inc., and Revolutionary Medical Devices, which develops products for airway management, improving patient outcomes from sedation and anaesthesia. He also serves on the Board at Augustine Medical a privately held market leader in medical arena temperature management and Inscope Inc., a venture capital- funded critical care firm.